Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: A sub-analysis of the COSMOS study

Clinical Drug Investigation

Volumn 32, Issue 7, 2012, Pages 439-449

  Vogelmeier, C ^a   Naya, I ^b   Ekelund, J ^c  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b ASTRAZENECA   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Asthma; budesonideformoterol; maintenance therapy; salmeterolfluticasone propionate

Indexed keywords

BECLOMETASONE; BUDESONIDE PLUS FORMOTEROL; DISKUS; FLUTICASONE PROPIONATE PLUS SALMETEROL; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; SALBUTAMOL; SMART; SYMBICORT TURBUHALER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASIAN; ASTHMA; CHINA; CLINICAL PRACTICE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; EMERGENCY WARD; FEMALE; FORCED EXPIRATORY VOLUME; HAZARD RATIO; HEADACHE; HOARSENESS; HOSPITALIZATION; HUMAN; INHALER; KOREA; MAINTENANCE DRUG DOSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHYSICIAN; POST HOC ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SORE THROAT; TAIWAN; THAILAND; UPPER RESPIRATORY TRACT INFECTION;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADULT; AGED; AGED, 80 AND OVER; ALBUTEROL; ANALYSIS OF VARIANCE; ANDROSTADIENES; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; LUNG; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PROPORTIONAL HAZARDS MODELS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862004897     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11598840-000000000-00000     Document Type: Article

References (24)

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2011
2. Bateman ED, Bousquet J, Braunstein GL. Is overall asthma control being achieved? A hypothesis-generating study. Eur Respir J 2001; 17 (4): 589-95 (Pubitemid 32492543)
3. Ind PW, Dal Negro R, Colman NC. et al. Addition of salmeterol to fluticasone propionate treatment in moderateto- severe asthma. Respir Med 2003; 97 (5): 555-62 (Pubitemid 36519529)
4. Edwards SJ, von Maltzahn R, Naya IP. et al. Budesonide/ formoterol for maintenance and reliever therapy of asthma: A meta analysis of randomised controlled trials. Int J Clin Pract 2010; 64 (5): 619-27
5. Gibson PG, Powell H, Ducharme FM. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations. J Allergy Clin Immunol 2007; 119 (2): 344-50 (Pubitemid 46206143)
6. Palmqvist M, Persson G, Lazer L. et al. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency. Eur Respir J 1997; 10 (11): 2484-9 (Pubitemid 28048620)
7. Pauwels RA, Sears MR, Campbell M. et al. Formoterol as relief medication in asthma: A worldwide safety and effectiveness trial. Eur Respir J 2003; 22 (5): 787-94 (Pubitemid 37369568)
8. Kuna P, Peters MJ, Manjra AI. et al. Effect of budesonide/ formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract 2007; 61 (5): 725-36 (Pubitemid 46587876)
9. Bousquet J, Boulet LP, Peters MJ. et al. Budesonide/ formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/ fluticasone. Respir Med 2007; 101 (12): 2437-46 (Pubitemid 350010579)
10. Demoly P, Louis R, Soes-Petersen U. et al. Budesonide/ formoterol maintenance and reliever therapy versus conventional best practice. Respir Med 2009; 103 (11): 1623-32
11. Vogelmeier C, D'Urzo A, Pauwels R. et al. Budesonide/ formoterol maintenance and reliever therapy: An effective asthma treatment option? Eur Respir J 2005; 26 (5): 819-28 (Pubitemid 41632038)
12. Juniper EF, O'Byrne PM, Guyatt GH. et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14 (4): 902-7 (Pubitemid 29519356)
13. Juniper EF, Buist AS, Cox FM. et al. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999; 115 (5): 1265-70 (Pubitemid 29230632)
14. Pedersen SE, Bateman ED, Bousquet J. et al. Determinants of response to fluticasone propionate and salmeterol/ fluticasone propionate combination in the Gaining Optimal Asthma controL study. J Allergy Clin Immunol 2007; 120 (5): 1036-42 (Pubitemid 350029898)
15. Rabe KF, Atienza T, Magyar P. et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: A randomised controlled, doubleblind study. Lancet 2006; 368 (9537): 744-53 (Pubitemid 44279053)
16. Tattersfield AE, Lofdahl CG, Postma DS. et al. Comparison of formoterol and terbutaline for as-needed treatment of asthma: A randomised trial. Lancet 2001; 357 (9252): 257-61 (Pubitemid 32120856)
17. Cates CJ, Lasserson TJ. Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev 2009; (2): CD007313
18. Chapman KR, Barnes NC, Greening AP. et al. Single maintenance and reliever therapy (SMART) of asthma: A critical appraisal. Thorax 2010; 65 (8): 747-52
19. Riemersma RA, Postma D, van der Molen T. Budesonide/ formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control. PrimCare Respir J 2012; 21 (1): 50-6
20. Bateman ED, Harrison TW, Quirce S. et al. Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res 2011; 12 (38)
21. Quirce S, Barcina C, Plaza V. et al. A comparison of budesonide/ formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain. J Asthma 2011; 48 (8): 839-47
22. Kuna P. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged †16 years with asthma: post hoc analysis of a randomized, double-blind study. Clin Drug Investig 2010; 30 (9): 565-79
23. Aalbers R. Fixed or adjustable maintenance-dose budesonide/ formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged †16 years: post hoc analysis of a randomized, doubleblind/ open-label extension, parallel-group study. Clin Drug Investig 2010; 30 (7): 439-51
24. Currie GP, Lee DK. The GOAL study: Designed to favor a long-acting beta2-agonist? Am J Respir Crit Care Med 2005; 171 (9): 1060-1; author reply 1